Liquid Biopsy as a Tool for Prognostic Assessment, Minimal Residual Disease Monitoring, and Systemic Therapy Guidance in Adrenocortical Carcinoma - 23 maggio 2025 - Rodrigo de Almeida Toledo, Vall d'Hebron Institute of Oncology (VHIO), Barcellona, Spagna